GoldP., FreedmanS.O.Cellular location of carcinoembryonic antigens of the human digestive system. Cancer Res, 1968; 28: 1331–3.
2.
CosimelliM., De PeggoF., GastelliM.The tissue CEA, TPA and CA 19.9 in colorectal cancer patients: preliminary results of a quantitative study. Journal of Tumor Marker Oncology1988; 3: 425–40.
3.
KesselD., SamsonK.M., ShahP.Alternations in plasma sialyl transferase associated with successful chemotherapy of a disseminated tumor. Cancer1976; 38: 2132–4.
4.
GanzingerU., DeutschE.Serum sialyltransferase levels as a parameter in the diagnosis and follow up of gastrointestinal tumors. Cancer Res1980; 40: 1300–4.
5.
DaoT., IpC., PatelJ.Serum sialyltransferase and 5' nucleotidase as reliable biomarkers in women with breast cancer. JNCI1980; 65: 529–34.
6.
YamazakiW., HayaishiO.Properties of nucleoside diphosphatase. J Biol Chem1968; 243: 2934–42.
7.
Papadopoulou-BoutisA., BoutisL., KaramfyllisT.Sialyltransferase and nucleoside diphosphatase as markers for tumor monitoring. Cancer Detection and Prevention1985; 8: 141–50.
8.
AntonoglouO., KaremfyllisT., BoutisL.Level of four enzymes in the serum of cancer patients. Anticancer Res1984; 4(suppl. 1): 1–2.
9.
KesselD., AllenJ.Elevated plasma sialyltransferase in cancer patients. Cancer Res1975; 35: 670–2.
10.
TamuraK., ShibataY., MatsudaY.Isolation and characterization of an IAP from ascitic fluids of cancer patients. Cancer Res1981; 41: 3244–52.
